Umoja Biopharma
Developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$840m—1.3b (Dealroom.co estimates Jun 2021.)
Seattle Washington (HQ)
Authorizing premium user...